Seeing Is Believing
ANEB is currently covered by 1 analysts
Anebulo Pharmaceuticals's activity chart (see below) currently has 8 price targets and 9 ratings on display. The stock rating distribution of ANEB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 23 days.
Highest price target for ANEB is $1, Lowest price target is $1.
Most recent stock forecast was given by MICHAEL OKUNEWITCH from MAXIM GROUP on 15-May-2025. First documented stock forecast 14-Feb-2023.
Currently out of the existing stock ratings of ANEB, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Sep-2023
$3
$1.95 (185.71%)
$6
Buy Since 18-Sep-2023
$6
$4.95 (471.43%)
$6
What is ANEB (Anebulo Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ANEB (Anebulo Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on ANEB (Anebulo Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ANEB (Anebulo Pharmaceuticals)?
Which analyst is the currently most bullish on ANEB (Anebulo Pharmaceuticals)?
Which analyst is the currently most reserved on ANEB (Anebulo Pharmaceuticals)?